Mittag, M <br/><br/>
Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels.  [electronic resource] 

 -  Acta dermato-venereologica   
 - 294-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0001-5555 
<br/><br/><label>Standard No.: </label>10.1080/00015550152572976  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Cell Adhesion Molecules--blood<br/>Cytokines--blood<br/>E-Selectin--blood<br/>Endothelial Growth Factors--blood<br/>Endothelin-1--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Iloprost--administration & dosage<br/>Infusions, Intravenous<br/>Intercellular Adhesion Molecule-1--blood<br/>Lymphokines--blood<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Raynaud Disease--blood<br/>Scleroderma, Systemic--blood<br/>Treatment Outcome<br/>Vascular Cell Adhesion Molecule-1--blood<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors